[Myocardial revascularization in patients with chronic renal failure].
The incidence of chronic renal failure has increased in the last years in industrialized countries. In Spain the prevalence of this pathology is estimated at 10-12% of the population, and the stages III-V of the disease, corresponding to the estimated glomerular filtration rate less than 60 ml/min/m2, represent the 5%. From the cardiovascular point of view, both chronic and acute coronary syndrome is a very important subgroup of patients because of the increased association between chronic renal failure and coronary artery disease. In fact, ACS is the main cause of death in patients with advanced chronic renal failure. Frequently, this kind of patients are excluded from prospective randomized clinical trials, consequently scientific evidence is not available to guide the therapy of coronary revascularization.
López Otero
D
D
Sección de Hemodinámica y Cardiología Intervencionista, Servicio de Cardiología, Hospital Clínico Universitario Santiago de Compostela, Santiago de Compostela, A Coruña, Spain. birihh@yahoo.es
Souto Castro
P
P
Trillo Nouche
R
R
González-Juanatey
J R
JR
D003324:Coronary Artery Disease / Q000150:complications* / Q000601:surgery*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D009204:Myocardial Revascularization